Advertisement

Topics

Furiex Pharmaceuticals Company Profile

23:48 EDT 28th May 2016 | BioPortfolio


News Articles [792 Associated News Articles listed on BioPortfolio]

RDD Pharma Appoints Dr. June Almenoff as Board Chairman

NEW YORK, Dec. 8, 2015 /PRNewswire/ -- RDD Pharma, a specialty pharma company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointmen...

ORIC Pharmaceuticals raises $53M for drugs that attack treatment-resistant cancers

ORIC Pharmaceuticals is being led by Richard Heyman, the serial biopharma entrepreneur behind companies like Aragon Pharmaceuticals, Seragon Pharmaceuticals and Metacrine.

Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Bafna Pharmaceuticals Limited (BAFNAPHARM) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. Thi...

SymBio Pharmaceuticals Limited (4582) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, SymBio Pharmaceuticals Limited (4582) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 25-...

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11....

Titan Pharmaceuticals And Braeburn Pharmaceuticals Announce FDA Advisory Committee Recommends Approval Of Probuphine

SOUTH SAN FRANCISCO, CA and PRINCETON, NJ – January 12, 2016 –Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and partner Braeburn Pharmaceuticals today announced that the Psychopharmacologic Drugs Advi...

Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Medical Union Pharmaceuticals Company (MEDU) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. T...

Novartis splits pharmaceuticals division into two business units

Novartis has announced internal structural changes that it says will “focus” its pharmaceuticals division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology, reporting ...

Drugs and Medications [0 Results]

None

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Removal of pharmaceuticals from secondary effluents by an electro-peroxone process.

This study compared the removal of pharmaceuticals from secondary effluents of wastewater treatment plants (WWTPs) by conventional ozonation and the electro-peroxone (E-peroxone) process, which involv...

Ranking Prescribed Pharmaceuticals in Terms of Environmental Risk: Inclusion of Hospital Data and the Importance of Regular Review.

A newly available dataset on pharmaceuticals used in Scottish hospitals enabled an Environmental Risk Assessment that includes hospital consumption of pharmaceuticals, as previous UK rankings have bee...

Uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin and propranolol, in Daphnia magna.

The objective of the present study was to investigate the uptake, depuration, and bioconcentration of two pharmaceuticals, roxithromycin (ROX) and propranolol (PRP), in Daphnia magna via aqueous expos...

Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models.

The acute toxicities of 36 pharmaceuticals towards green algae were estimated from a set of quantile regression models representing the first global quantitative structure-activity relationships. The ...

Assessing environmental risk of pharmaceuticals in Portugal: An approach for the selection of the Portuguese monitoring stations in line with Directive 2013/39/EU.

In line with the Directive 2013/39/EU the most representative surface waters, regarding pharmaceuticals contamination, were selected based on a Portuguese nationwide monitoring exercise. To meet this ...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Furiex Pharmaceuticals" on BioPortfolio

We have published hundreds of Furiex Pharmaceuticals news stories on BioPortfolio along with dozens of Furiex Pharmaceuticals Clinical Trials and PubMed Articles about Furiex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Furiex Pharmaceuticals Companies in our database. You can also find out about relevant Furiex Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record